UBS Group AG - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 55 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$55,509
-38.2%
14,053
-51.0%
0.00%
Q2 2023$89,784
+233.6%
28,685
+382.7%
0.00%
Q1 2023$26,917
+8963.0%
5,942
+8152.8%
0.00%
Q4 2022$297
-97.3%
72
-97.8%
0.00%
Q3 2022$11,000
+1000.0%
3,345
+456.6%
0.00%
Q2 2022$1,000
-85.7%
601
-65.3%
0.00%
Q1 2022$7,000
-41.7%
1,733
+54.6%
0.00%
Q4 2021$12,0001,121
+13912.5%
0.00%
Q3 2021$080.0%0.00%
Q2 2021$080.0%0.00%
Q1 2021$0
-100.0%
8
-97.3%
0.00%
Q4 2020$6,0002990.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 1,515,148$32,439,0009.14%
ACUTA CAPITAL PARTNERS, LLC 863,100$18,479,0005.03%
SILVERARC CAPITAL MANAGEMENT, LLC 217,203$4,650,0002.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,144,539$110,145,0002.18%
Atlas Venture Advisors, Inc. 292,184$6,256,0001.40%
Logos Global Management LP 715,000$15,308,0001.31%
Sio Capital Management, LLC 188,661$4,039,0000.83%
Vivo Capital, LLC 799,662$17,121,0000.76%
Altium Capital Management LP 93,261$1,997,0000.75%
RA Capital Management 1,515,151$32,439,0000.45%
View complete list of LARIMAR THERAPEUTICS INC shareholders